文献速递神经眼科眼底病与葡萄膜炎

基于OCT的视网膜评估反映多发性硬化患者的视觉损害

OCT-Based Retina Assessment Reflects Visual Impairment in Multiple Sclerosis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

研究纳入137例多发性硬化患者(271眼)和118名健康对照(236眼),于2018至2020年进行OCT及视觉功能评估并随访1年。发现患者pRNFL和mGCIPL体积均降低,pRNFL低于特定切点值时出现视觉损害切点效应,AULCSF与视网膜萎缩相关性最强,mGCIPL体积与视觉测试关联更强且无切点效应。

要点

  • 多发性硬化患者pRNFL为92 µm vs 健康对照98 µm(P < 0.001),mGCIPL体积为0.55 mm3 vs 0.62 mm3(P < 0.001)。
  • 患者pRNFL低于68.8 µm(HCVA)、71.4 µm(LCVA)和72.6 µm(AULCSF)时出现视觉损害切点效应。
  • mGCIPL体积与AULCSF关联最强(P < 0.001),且无视神经炎作为显著影响因素(P < 0.001)。

核心结论

  • AULCSF优于标准HCVA和LCVA,能密切反映视网膜萎缩。
  • mGCIPL丢失与视觉测试关联更强,且能检测神经变性而无pRNFL所见的切点效应,使其成为神经元萎缩的最佳标志物。

研究设计与样本

  • 从两个神经科转诊中心收集多发性硬化患者和健康对照的数据。
  • 于2018年至2020年间进行神经科和眼科评估,包括OCT、HCVA、LCVA、AULCSF和视功能相关生活质量问卷,并在1年时随访。
  • 共137例多发性硬化患者(271眼)和118名健康对照(236眼)纳入分析。

主要发现

  • 多发性硬化患者pRNFL为92 µm vs 健康对照98 µm(P < 0.001),mGCIPL体积为0.55 mm3 vs 0.62 mm3(P < 0.001),均降低。
  • 多发性硬化患者中pRNFL低于68.8 µm(HCVA)、71.4 µm(LCVA)和72.6 µm(AULCSF)时出现视觉损害切点效应。
  • 混合效应模型显示mGCIPL体积是与AULCSF关联最强的变量(P < 0.001)。
  • AULCSF与pRNFL和mGCIPL均显示最强相关性(P < 0.001),视神经炎为显著影响因素(P < 0.001)。

关键数值与推荐

  • 多发性硬化患者pRNFL为92 µm vs 健康对照98 µm(P < 0.001)。
  • 多发性硬化患者mGCIPL体积为0.55 mm3 vs 健康对照0.62 mm3(P < 0.001)。
  • 视觉损害切点:pRNFL低于68.8 µm对应HCVA,低于71.4 µm对应LCVA,低于72.6 µm对应AULCSF。
  • mGCIPL体积与AULCSF关联的P < 0.001;AULCSF与pRNFL和mGCIPL相关性的P < 0.001;视神经炎贡献的P < 0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To explore the relationship between visual performance and retinal morphology as assessed by optical coherence tomography (OCT), and the ability of OCT to reflect visual impairment in people with multiple sclerosis (PwMS) compared with healthy controls (HC). METHODS: We gathered data from two neurology referral centers on PwMS and HC. Neurological and ophthalmological assessments, including OCT, high-contrast visual acuity (HCVA) and low-contrast visual acuity (LCVA), area under the log contrast sensitivity function (AULCSF), and vision-related quality of life (National Eye Institute Visual Function Questionnaire), were conducted between 2018 and 2020, with follow-up at 1 year. RESULTS: A total of 137 PwMS (271 eyes) and 118 HC (236 eyes) were available for analysis. The peripapillary retinal nerve fiber layer (pRNFL) and the macular ganglion cell layer and inner plexiform layer volume (mGCIPL) volume were both reduced in PwMS (92 µm in PwMS vs 98 µm in HC [P < 0.001], 0.55 mm3 vs 0.62 mm3 [P < 0.001], respectively). A cutoff effect for visual impairment was observed in PwMS when pRNFL fell below 68.8 µm (HCVA), 71.4 µm (LCVA), and 72.6 µm (AULCSF). Using mixed effects models, the mGCIPL volume emerged as the variable most strongly associated with the AULCSF (P < 0.001). The AULCSF showed the strongest correlation with both pRNFL and mGCIPL (P < 0.001), with optic neuritis being a significant contributing factor (P < 0.001). CONCLUSIONS: AULCSF outperformed standard HCVA and LCVA, closely reflecting retinal atrophy. mGCIPL loss showed stronger associations with vision tests and detected neurodegeneration without the cutoff effect seen in pRNFL, making it the best marker for neuronal atrophy.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Stolowy N, Gutmann L, Lüpke M, et al. OCT-Based Retina Assessment Reflects Visual Impairment in Multiple Sclerosis. Invest Ophthalmol Vis Sci. 2025. PMID: 39946137. doi:10.1167/iovs.66.2.39

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。